AG
AERI

Aperio Group’s Aerie Pharmaceuticals AERI Stock Holding History

Aperio Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.07M Buy
79,106
+9,978
+14% +$121K ﹤0.01% 1562
2020
Q3 		$814K Buy
69,128
+55,684
+414% +$678K ﹤0.01% 1553
2020
Q2 		$198K Sell
13,444
-221
-2% -$3.27K ﹤0.01% 2180
2020
Q1 		$185K Sell
13,665
-2,770
-17% -$52.6K ﹤0.01% 2112
2019
Q4 		$398K Buy
16,435
+3,166
+24% +$65.6K ﹤0.01% 1928
2019
Q3 		$255K Buy
13,269
+5,496
+71% +$126K ﹤0.01% 2087
2019
Q2 		$230K Sell
7,773
-1,257
-14% -$48.4K ﹤0.01% 2129
2019
Q1 		$429K Buy
9,030
+2,184
+32% +$96.1K ﹤0.01% 1840
2018
Q4 		$247K Buy
6,846
+1,591
+30% +$74.6K ﹤0.01% 2038
2018
Q3 		$323K Sell
5,255
-18
-0.3% -$1.16K ﹤0.01% 1974
2018
Q2 		$356K Sell
5,273
-369
-7% -$20.6K ﹤0.01% 1924
2018
Q1 		$306K Sell
5,642
-79
-1% -$4.42K ﹤0.01% 1948
2017
Q4 		$342K Buy
5,721
+504
+10% +$30.6K ﹤0.01% 1880
2017
Q3 		$253K Buy
5,217
+303
+6% +$16.5K ﹤0.01% 2020
2017
Q2 		$259K Buy
4,914
+219
+5% +$10.2K ﹤0.01% 1969
2017
Q1 		$213K Buy
+4,695
New +$209K ﹤0.01% 2010

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Aperio Group's AERI Position: Q4 2020 in Review

Aperio Group increased its Aerie Pharmaceuticals (AERI) stake by 14% in Q4 2020, buying an estimated $121K and bringing the position to 79,106 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

Aperio Group first reported a position in AERI in Q1 2017 and has held it in 16 quarters since. 150 funds tracked by Wall St. Rank hold AERI as of Q4 2020.

  • Aperio Group held 79,106 shares of Aerie Pharmaceuticals worth $1.07M as of Q4 2020.
  • Aperio Group bought 9,978 Aerie Pharmaceuticals shares in Q4 2020, an estimated $121K.
  • Aerie Pharmaceuticals made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1562 holding.
  • Aperio Group first reported a position in Aerie Pharmaceuticals in Q1 2017 and has held it in 16 quarters since.
  • 150 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.